Search research articles
Contact Us
Filters
Showing results (191-200 of 298) with videos related to
Page
of 30
Sort By:
Hepatology (Baltimore, Md.)
|
May 23, 2013
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
Mazen Noureddin, Jessica Lam, Michael R Peterson, et al.
JHEP Reports : Innovation in Hepatology
|
June 18, 2025
DHCR7 inhibition ameliorates MetALD and HCC in mice and human 3D liver spheroids
Gen Yamamoto, Raquel Carvalho-Gontijo Weber, Wonseok Lee, et al.
Journal of the American College of Cardiology
|
February 19, 2014
Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke)
Todd M Brown, Jenifer H Voeks, Vera Bittner, et al.
The Journal of Clinical Investigation
|
March 19, 2005
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury
Tom Luedde, Ulrike Assmus, Torsten Wüstefeld, et al.
International Journal of Molecular Medicine
|
June 20, 2017
Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice
Min Cong, Weihua Zhao, Tianhui Liu, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
A Translational Model of MASLD-Associated HFpEF Defines Mitochondrial Dysfunction and Cardiac Plasticity During Disease Progression and Regression
Souradipta Ganguly, Betul Gunes, Yusu Gu, et al.
Hepatology (Baltimore, Md.)
|
July 19, 2012
Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent
Tomonori Aoyama, Yong-Han Paik, Sumio Watanabe, et al.
Metabolism: Clinical and Experimental
|
June 22, 2026
A translational model of MASLD-associated HFpEF defines mitochondrial dysfunction and cardiac plasticity during disease progression and regression
Souradipta Ganguly, Betul Gunes, Yusu Gu, et al.
Cell Metabolism
|
August 3, 2022
Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis
Hong Gao, Zhongmou Jin, Gautam Bandyopadhyay, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 30, 2011
Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase
David A Brenner, Ekihiro Seki, Kojiro Taura, et al.
Page
of 30
Search research articles
Search
Showing results (191-200 of 298) with videos related to
Sort By:
Page
of 30
Hepatology (Baltimore, Md.)
|
May 23, 2013
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
Mazen Noureddin, Jessica Lam, Michael R Peterson, et al.
JHEP Reports : Innovation in Hepatology
|
June 18, 2025
DHCR7 inhibition ameliorates MetALD and HCC in mice and human 3D liver spheroids
Gen Yamamoto, Raquel Carvalho-Gontijo Weber, Wonseok Lee, et al.
Journal of the American College of Cardiology
|
February 19, 2014
Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke)
Todd M Brown, Jenifer H Voeks, Vera Bittner, et al.
The Journal of Clinical Investigation
|
March 19, 2005
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury
Tom Luedde, Ulrike Assmus, Torsten Wüstefeld, et al.
International Journal of Molecular Medicine
|
June 20, 2017
Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice
Min Cong, Weihua Zhao, Tianhui Liu, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
A Translational Model of MASLD-Associated HFpEF Defines Mitochondrial Dysfunction and Cardiac Plasticity During Disease Progression and Regression
Souradipta Ganguly, Betul Gunes, Yusu Gu, et al.
Hepatology (Baltimore, Md.)
|
July 19, 2012
Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent
Tomonori Aoyama, Yong-Han Paik, Sumio Watanabe, et al.
Metabolism: Clinical and Experimental
|
June 22, 2026
A translational model of MASLD-associated HFpEF defines mitochondrial dysfunction and cardiac plasticity during disease progression and regression
Souradipta Ganguly, Betul Gunes, Yusu Gu, et al.
Cell Metabolism
|
August 3, 2022
Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis
Hong Gao, Zhongmou Jin, Gautam Bandyopadhyay, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 30, 2011
Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase
David A Brenner, Ekihiro Seki, Kojiro Taura, et al.
Page
of 30